Vanderbilt Ingram Cancer Center
-
VICC debuts novel neuroendocrine tumor treatment
A retired elementary school principal has become the first patient at Vanderbilt-Ingram Cancer Center to receive an investigational cancer therapy for the treatment of his neuroendocrine tumor. Read MoreApr 24, 2014
-
VICC research takes center stage at national meeting
Research led by Joan Garrett, Ph.D., research instructor in Hematology/Oncology, reveals a molecular mechanism that may explain why some forms of breast cancer become resistant to therapy. Read MoreApr 24, 2014
-
VICC’s Arteaga assumes presidency of AACR
Carlos L. Arteaga, M.D., professor of Medicine and Cancer Biology and Donna S. Hall Professor of Breast Cancer Research at Vanderbilt-Ingram Cancer Center (VICC), assumed the presidency of the American Association for Cancer Research (AACR) for 2014-2015 during the group’s annual meeting last week in San Diego. Read MoreApr 17, 2014
-
Free head and neck cancer screening event set for April 25
Vanderbilt-Ingram Cancer Center and the Vanderbilt Department of Otolaryngology will hold the annual head and neck cancer screening event Friday, April 25, 9 a.m. – 3 p.m. The screenings are free, open to the public and require no appointment. Read MoreApr 17, 2014
-
Photo: In good hands
The Allstate WBCA Good Works Team partnered with the Kay Yow Cancer Fund to distribute wellness kits to patients at the Vanderbilt-Ingram Cancer Center this week to celebrate the NCAA Division 1 Women’s Basketball Championship held in Nashville. Read MoreApr 10, 2014
-
Photo: Sarcoma research support
The FTL Sarcoma Fund, in partnership with the T.J. Martell Foundation, recently presented a gift to the Vanderbilt-Ingram Cancer Center in support of sarcoma research in memory of Warner Music Nashville colleague Lindsay Walleman. Read MoreApr 10, 2014
-
Call for artists: ‘Courage Unmasked’
Sarratt Art Studios and the Sarratt Gallery are partnering with the Vanderbilt Ingram Cancer Center to present “Courage Unmasked 2014.” Read MoreApr 4, 2014
-
T.J. Martell Foundation lauds Hiebert’s research
Scott Hiebert, Ph.D., associate director of Basic Research at Vanderbilt-Ingram Cancer Center (VICC), was celebrated for his contributions to cancer research during the 6th Annual Nashville Honors Gala benefiting the T.J. Martell Foundation. Read MoreMar 20, 2014
-
A new way to target cancer-driver Ras
Vanderbilt researchers have discovered small molecules that turn off cancerous Ras signals in a new way. Read MoreMar 13, 2014
-
Probing the pathogenesis of leukemia
A new mouse model reveals gene clusters important in a treatment-resistant form of leukemia. Read MoreFeb 27, 2014
-
Studies shed new light on breast cancer development
Rebecca Cook, Ph.D., assistant professor of Cancer Biology, has spent her life trying to understand what makes things grow, from seedlings in soil to tumor cells in the body. Read MoreFeb 20, 2014
-
Agreement sets stage for enhanced My Cancer Genome
Vanderbilt-Ingram Cancer Center (VICC) and GenomOncology have announced an agreement for the exclusive commercial development of a decision support tool based on My Cancer Genome, an online precision cancer medicine knowledge resource for physicians, patients, caregivers and researchers. Read MoreFeb 13, 2014
-
Photo: Blackhawk visits
The musical group Blackhawk recently performed for patients at Vanderbilt-Ingram Cancer Center. The group raises funds for the Cancer Center in honor of former bandmate Van Stephenson, who died from melanoma. Read MoreFeb 13, 2014
-
VICC debuts lung cancer screening program
Vanderbilt-Ingram Cancer Center has launched a new lung cancer screening program to provide low-dose CT scans for patients at high risk for the deadly disease. Current or former smokers ages 55 to 74 who have a history of 30 or more pack years of smoking are eligible for the scans. Read MoreJan 30, 2014
-
VICC receives $100,000 ovarian cancer research grant
The Kay Yow Cancer Fund, in partnership with the Women’s Basketball Coaches Association and The V Foundation for Cancer Research, has awarded a $100,000 ovarian cancer research grant to the Vanderbilt-Ingram Cancer Center. Read MoreJan 21, 2014
-
Vanderbilt-Ingram Cancer Center receives $100,000 ovarian cancer research grant from Kay Yow Cancer Fund
L-r: Lawrence Marnett, Mary Geddes Stahlman Professor of Cancer Research; Vanderbilt women’s head basketball coach Melanie Balcomb; Susan Donohoe, executive director of the Kay Yow Cancer Fund; Mayor Karl Dean; Vanderbilt-Ingram Cancer Center Director Jennifer Pietenpol; and Assistant Professor of Obstetrics and Gynecology Dineo Khabele were on hand for… Read MoreJan 21, 2014
-
Targeting tumor “supply lines”
A metabolic enzyme plays a crucial role in vascular development and may be a good target for cancer therapies. Read MoreDec 18, 2013
-
Research climate must be enhanced: NCI director
The director of the National Cancer Institute, Harold Varmus, M.D., told an overflow crowd at this year’s Orrin Ingram Distinguished Lecture that he is concerned about the climate for discovery research in the United States. Read MoreDec 5, 2013
-
Therapeutic target for synovial sarcoma
Inhibitors of a signaling pathway that is critical to synovial sarcoma tumorigenesis may be useful treatments for this aggressive cancer. Read MoreNov 21, 2013
-
Photo: Cancer survivorship celebration
More than 650 cancer survivors, family members and cancer health care providers attended Vanderbilt-Ingram Cancer Center’s Cancer Survivorship Celebration earlier this month during a special evening dinner and concert at the Loveless Barn in Nashville. Read MoreNov 21, 2013